|
|
||||||||||
|
J Am Coll Cardiol, 2000; 36:219-226 © 2000 by the American College of Cardiology Foundation |




* Institute of Internal Medicine, Naples, Italy
Institute of Nuclear Medicine, Faculty of Medicine, 2nd University of Naples, University "Federico II" of Naples, Naples, Italy, Institute of Internal Medicine
Institute of Cardiology, University "Federico II" of Naples, Naples, Italy, Institute of Internal Medicine
Department of Clinical and Experimental Medicine, University "Federico II" of Naples, Naples, Italy
Manuscript received March 5, 1998; revised manuscript received December 10, 1999, accepted March 27, 2000.
Reprint requests and correspondence: Dr. Ferdinando Carlo Sasso, Via A. Fontana, 81 (Parco Lamaro, Palazzina 15), Napoli, Italy
ferdinando.sasso{at}unina2.it
| Abstract |
|---|
|
|
|---|
The aim of this study was to evaluate: 1) the effects of insulin administration on left ventricular ejection fraction (LVEF) during exercise, and 2) the eventual impairment of the cardiovascular response to insulin in noninsulin dependent diabetes mellitus.
BACKGROUND
Insulin influences the cardiovascular system, but its effect on left ventricular function has yet to be established.
METHODS
The effects of normal saline (test A) and insulin-glucose (insulin = 1.7 mU·kg1·min1; glucose = 6 mg·kg1·min1) (test B) infusions on systolic and diastolic functions at rest and during dynamic exercise were examined by radionuclide ventriculography. Twenty-two noninsulin-dependent diabetic patients and 22 gender, age and body mass index matched healthy subjects were investigated.
RESULTS
Both groups had normal scintigraphic parameters at rest and during dynamic exercise. Rest- and stress-LVEF as well as rest- and stress-peak filling rate were significantly (p < 0.001) lower in diabetic than in healthy subjects, both in test A and B. Rest-LVEF was significantly higher during test B than it was in test A only in diabetic subjects (p < 0.01). Stress-LVEF was significantly higher (p < 0.05) during test B than it was in test A, in both groups. Insulin-glucose infusion did not modify rest- and stress-peak filling rate in either group. No difference in left ventricular end diastolic volume and in mean blood pressure was found between test A and B at rest and during exercise in either group. A significant linear correlation between LVEF and the index of insulin sensitivity was found in diabetic patients.
CONCLUSIONS
In both normal and diabetic humans, insulin induces a very important rise in LVEF after submaximal work. However, the rise is significantly lower in diabetic than in nondiabetic subjects. The increase in exercise-LVEF on insulin is likely due to an enhancement of ventricular contractility. Insulin resistance could justify the lower angioscintigraphic indexes in diabetic subjects.
| ||||||||||||||||||||||||
In this novel area of human research, two aspects have not been investigated until now: 1) the effects of insulin administration on LVEF during exercise, 2) the eventual impairment of the cardiovascular response to insulin in noninsulin dependent diabetes mellitus (NIDDM), a condition notoriously associated with insulin resistance.
This study aimed to explore these topics. Cardiac function was examined in healthy subjects and NIDDM patients using resting and exercise radionuclide ventriculography during both saline and double insulin-glucose infusion at prefixed rates.
| Methods |
|---|
|
|
|---|
|
Subjects with ECG abnormalities at rest or with downsloping or horizontal ST segment depression during a treadmill maximal exercise electrocardiography performed according to the Bruce protocol (8) or with left ventricular segmental asynergy assessed by M-mode and two-dimensional echocardiography or with rest or stress myocardial perfusion imaging performed after infusion of 3 mCi of 201mT1 suggestive of ischemic heart disease were not enrolled.
Microangiopathy was excluded by ophtalmological evaluation using direct fundoscopy within one month before the study and by measuring excretion of albumin on a timed 24-h collection of urine (all subjects studied had albumin excretion <20 mg/24 h).
No difference in autonomic neural function was detected between nondiabetic and diabetic subjects as assessed by the heart rate responses to deep breathing, to Valsalva maneuver and to standing and by the blood pressure response to standing (Table 2). These tests were in age-related normal ranges (9) for all subjects. Peripheral neuropathy was not evaluated, as it had no influence on left ventricular function (10).
|
Protocol. Each group underwent two multiple-gated radionuclide ventriculographies, one during infusion of normal saline (test A) and the other during a double insulin-glucose infusion at prefixed rates (insulin = 1.7 mU·kg1·min1; glucose = 6 mg·kg1·min1) (test B). The studies were randomly performed on two different occasions, five to seven days apart.
The consumption of glybenclamide, alcohol, tea and coffee was avoided for 12 h before and during each experiment.
Subjects were studied in the supine position in a quiet room at 20°C after an overnight 14-h fast.
The left arm was utilized for blood pressure measurements, using a mercury sphygmomanometer with systolic and diastolic blood pressures measured at Korotkoffs 1st and 5th sounds, respectively. Mean blood pressure (MBP) was calculated from the sum of diastolic blood pressure plus one-third of the arterial pulse pressure.
For the blood samples, a venous cannula was inserted retrograde in a right hand vein and flushed with saline at a rate of 0.5 ml·min1, the hand being maintained in a hand warmer at 65°C. For the infusions, a second cannula was inserted in a vein of the antecubital fossa of the same side.
In test B, insulin (Humulin R; Ely Lilly, Basingskoke, United Kingdom) was diluted in albumin, and normal saline was added to obtain a concentration of 1.7 mU per kg of patient body weight per milliliter, and a 50% dextrose solution was diluted with normal saline to obtain a concentration of 6 mg per kg of patient body weight per ml and added with K2HPO4 (
0.0038 me·Kg1·ml) to prevent hypokalemia and hypophosfatemia. Both solutions were infused at a rate of 1 ml per min.
Test A was performed by infusing normal saline at a rate of 2 ml per min to give the same fluid load as test B.
After obtaining a basal blood sample, insulin-glucose infusion (test B) was started and maintained for 120 min to achieve the steady-state condition. Infusion was maintained for 120 min also during test A.
Successively, scintigraphic acquisition at rest was made and, then, exercise started without stopping the saline or insulin-glucose infusion until completion of stress scintigraphic scan.
The stress consisted of supine dynamic exercise on a bicycle ergometer, beginning with 25 W at 60 rpm and increasing by 25 W steps over 2 min until reaching the 75 W load. This work was maintained for 4 min for the stress scintigraphic scan.
During exercise, the subjects were submitted to ECG-standard recordings every 2 min.
For radionuclide angiography, red blood cells were labelled "in vivo" with 25 mCi of 99mTc pertechnetate. The studies were carried out with a small field of view Gamma camera (Basicam SIEMENS, Erlangen, Germany) equipped with a low-energy, general purpose, parallel hole collimator. Energy discrimination was provided by a 20% window centered over the 140-keV photopeak of 99mTc. A five million count study was made in 45° left anterior oblique view with a 15° of caudal tilt, using the positioning of the camera, which maximized the separation of blood pool activity in the left and right ventricles. Data were acquired in frame-mode by computer-based electrocardiographic gating with a 1.5x digital zoom. The cardiac cycle was divided into 24 frames, and data for each frame were collected in a 64 x 64 matrix. The imaging rate was 50 frames/s (or 20 ms/frame) with a gate tolerance of ±5%. Left ventricular ejection fraction and peak filling rate (PFR) were calculated by a standard computed software (11,12). Left ventricular end diastolic volume (LVEDV) was calculated by the Massardo et al. (13) method. Angioscintigraphic parameters were evaluated at rest and at 75 W.
Blood samples for glucose, potassium and insulin determinations were taken at 0, 30, 60, 90, 100, 110 and 120 min and at the end of each work step. Plasma C-peptide levels were measured at 0 and 120 min only during test B to calculate the metabolic clearance rate of insulin. Plasma adrenaline and noradrenaline levels were assessed at rest, at the steady-state condition and at the end of the last work step in both tests.
Heart rate (from electrocardiogram) and blood pressure values were taken at basal conditions, before starting exercise and every 2 min during dynamic exercise. Each blood pressure determination was an average of at least two measurements.
Calculations, analytic methods and statistics. Steady-state (90120 min) plasma glucose (SS-G), steady-state plasma insulin (SS-I), metabolic clearance rate of glucose (MCR-G), insulin sensitivity index (ISI = MCR-G/SS-I·100) and metabolic clearance rate of insulin (MCR-I) were calculated for test B, as elsewhere reported (14).
Plasma glucose was measured by a glucose oxidase method (Beckman glucose analyzer II, Fullerton, California). Plasma insulin and C-peptide were assayed with radioimmunological technique using specific kits (INCSTAR Corporation, Stillwater, Minnesota). Plasma adrenaline and noradrenaline concentrations were determined by high performance liquid chromatography. Glycosylated hemoglobin A1c was determined by column chromatography using a commercial kit (BIO-RAD, Hercules, California) (values less than 7.0% indicated good glycemic control in diabetic patients). Urine albumin was measured by radioimmunoassay technique; the lowest detection limit was 1.5 µg/ml.
Statistical analysis was made by one-way analysis of variance (ANOVA). When differences were significant, Student t tests for paired and unpaired data were performed. Effect of insulin on angioscintigraphic parameters in diabetic and healthy subjects was analyzed by multivariate two-way ANOVA with repeated measures. Simple regression was applied to evaluate correlations between ISI and scintigraphic parameters. The computer software package SPSS for Windows, version 7.5, was used.
The level of statistical significance chosen was p < 0.05. Data in the text and Tables 1 through 5 are expressed as mean ± SD.
| Results |
|---|
|
|
|---|
During exercise, patients and controls achieved 75% to 80% of the maximal ideal heart rate.
Metabolic/hormonal parameters. Test A (Fig. 1).
|
Test B (Fig. 2). Plasma glucose was significantly (p < 0.001) higher in diabetic than it was in healthy subjects during the entire test duration. Plasma insulin levels were significantly (p < 0.05 or less) higher in diabetic subjects at all times.
|
|
Similar rest and stress noradrenaline and adrenaline responses were observed between controls and diabetics in both tests (Table 4).
|
Angioscintigraphic parameters. Each healthy and diabetic subject showed a normal (>50%) LVEF at rest.
Diabetic versus healthy subjects (Table 5). During test A, resting and exercise-LVEF, resting and exercise-PFR and change in LVEF were significantly (p < 0.001) lower in diabetic subjects. No significant difference was found for rest-LVEDV and stress-LVEDV between the two groups.
|
A significant positive correlation was found in diabetic patients between LVEF and ISI both at rest (r = 0.59; p < 0.004) and during exercise (r = 0.58; p < 0.005) (Fig. 3).
|
Two-way repeated measures ANOVA (Table 6)
|
| Heart rate and blood pressure |
|---|
|
|
|---|
| Discussion |
|---|
|
|
|---|
The results seem to indicate that, in healthy subjects, supraphysiological plasma levels of insulin are able to substantially increase LVEF in response to submaximal dynamic exercise, whereas they do not influence this parameter at rest. An echocardiographic study (15) has also shown that moderate hyperinsulinemia, induced by intravenous insulin infusion with euglycemic clamp technique, has no effect on ejection phase indexes in healthy supine subjects. Conversely, there is no data in the literature concerning insulins effect on left ventricular function during dynamic stress.
Cardiovascular effects of insulin. The mechanism underlying the cardiovascular effects of insulin and their evaluation are complex. In agreement with some authors (16) but not with others (17), we found no difference in left ventricular end diastolic volume or in blood pressure between saline and insulin-glucose infusion. Thus, an influence of preload or afterload on LVEF can be reasonably excluded, and the observed modifications of LVEF on insulin likely express the status of left ventricular contractility.
In agreement with the literature (1820) diabetic patients showed an impaired diastolic function compared with healthy subjects, both at rest and during exercise, as evaluated by PFR. Moreover, insulin-glucose infusions do not modify these diastolic parameters in either group.
The first question to be addressed is whether the increase in ejection fraction during exercise observed for insulin is an expression of the hormones direct action on the heart.
The similar heart rate changes from rest to exercise with or without insulin-glucose infusion do not suggest changes in sympathetic drive, as confirmed by plasma catecholamine levels.
A direct inotropic effect of insulin has been suggested by some authors. Experimental studies on cats and lambs have shown that intravenous insulin increases myocardial contractility, without being mediated by glucose or catecholamine (1,2). However, studies on dogs and rats have failed to demonstrate a positive inotropic effect in either intact hearts or isolated cardiac muscle (2123).
Metabolic hypothesis.
We hypothesize that enhanced left ventricular function observed after insulin may be due to the metabolic effects of the hormone. In resting fasting humans, heart muscle takes up significant amounts of free fatty acids, lactate, pyruvate, glycerol and beta-hydroxybutyrate, that is, it preferentially uses substrates that yield energy through mitochondrial metabolism, while glycolysis normally produces only
30% of energy (2428). Physiological hyperinsulinemia specifically enhances myocardial glucose, lactate and pyruvate uptake, converting cardiac fuel reliance from fat to carbohydrate (16). A similar shift of circulating substrate uptake and oxidation by the heart has been observed during atrial pacing (29). Conversely, during exercise lactate becomes the most important source of energy for the heart (26). These findings suggest that hyperinsulinemia during dynamic stress may increasingly favor myocardial carbohydrate oxidation and, consequently, improve cardiac performance in healthy subjects.
Role of diabetes on systolic function. The noninsulin-dependent diabetic patients we examined by radionuclide angioscintigraphy showed normal LVEF and normal rise in this parameter on supine dynamic exercise. Nevertheless, their LVEF at rest and under stress and both on saline or insulin was significantly lower than that of a healthy population matched for age, gender and body mass index.
Our diabetic patients were relatively young; disease duration was short, and they were in good metabolic control. Moreover, coronary artery disease, microangiopathy, autonomic neuropathy and any cardiovascular abnormalities detectable by noninvasive techniques were excluded early. Due to these strict exclusion criteria, it is reasonable that only diabetes could have conditioned this depressed, albeit normal, systolic function in the diabetic group. The use of glybenclamide could have played a role. However, a positive (rather than negative) inotropic effect on the heart has been reported only for tolbutamide (30). In this regard, no data are available for second and third generation sulphonylureas.
Unlike healthy subjects, the LVEF of diabetic patients after insulin significantly increased not only during exercise but even at rest. However, despite the higher steady-state that plasma insulin levels reached during insulin-glucose infusion (likely induced by their lower metabolic clearance rate of the hormone), the diabetic group showed a significant decline in the percent rise of the ejection fraction in response to work.
These differences cannot be justified by the behavior of afterload, preload or catecholamine levels.
If it is true that the increment of the exercise-LVEF on insulin in healthy subjects is mediated by the metabolic effects of the hormone, the lower angioscintigraphic indexes observed in NIDDM subjects could be justified by their insulin resistance, as suggested by the significant linear correlation between LVEF and the ISI found in these patients.
In diabetic patients at rest, insulin infusion partially compensates the gap with the healthy subjects, by improving the yield of metabolic glucose pathways and cardiac performance. In the same patients, the stress-induced increase of LVEF is, conversely, less important during insulin than during saline infusion, perhaps because of overburdened heart glucose metabolism.
Metabolism in the diabetic heart. This may be in agreement with the finding of metabolic defects within myocardial postreceptors in a streptozotocin-induced rat model of NIDDM, which lead to a significant basal and insulin-stimulated reduction in glucose oxidation and ATP synthesis from glucose (31) and a parallel decrease in the maximal stimulation of cardiac work by insulin (32). However, studies on humans utilizing positron emission tomography to determine regional glucose utilization rates have failed to document decreased glucose uptake in either type-1 (33) or type-2 (34) diabetic patients, despite a reduced rate of whole body glucose uptake. Thus, skeletal muscle and heart insulin resistance do not seem to coexist. These findings do not exclude defects within successive steps of carbohydrate oxidation, which may limit the rate of glycolysis and the Krebs cycle in the diabetic heart. It has been found that insulin has an independent effect on lactate oxidation in the canine heart, suggesting the direct activation of pyruvate dehydrogenase (35). Ferrannini et al. (16) observed in humans that physiological hyperinsulinemia increases the hearts lactate extraction rate more than two-fold. Based on these data, a defect of pyruvate dehydrogenase may be hypothesized in the diabetic heart, and the cardiac insulin resistance may be suggested as a possible background factor for the development of the "diabetic cardiomyopathy" in type-2 diabetes.
In conclusion, our study is the first to show that supraphysiological levels of circulating insulin in normal humans do not modify LVEF at rest, but significantly increase it in response to a submaximal work, as assessed by radionuclide ventriculography. In noninsulin-dependent diabetic subjects, this increment also occurs at rest, even when both rest and stress-LVEF appear to be significantly lower in this population than it is healthy subjects. Further investigations need to interpret the physiological mechanisms and significance of the synergy between exercise and insulin on LVEF and confirm the eventual relationship between insulin resistance in the heart and the left ventricular systolic hypofunction in NIDDM.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
Z. Lu, Y.-P. Jiang, X.-H. Xu, L. M. Ballou, I. S. Cohen, and R. Z. Lin Decreased L-Type Ca2+ Current in Cardiac Myocytes of Type 1 Diabetic Akita Mice Due to Reduced Phosphatidylinositol 3-Kinase Signaling Diabetes, November 1, 2007; 56(11): 2780 - 2789. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. T. Vestergaard, N. H. Andersen, T. K. Hansen, L. M. Rasmussen, N. Moller, K. E. Sorensen, E. Sloth, and J. O. L. Jorgensen Cardiovascular effects of intravenous ghrelin infusion in healthy young men Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H3020 - H3026. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. G. Poornima, P. Parikh, and R. P. Shannon Diabetic Cardiomyopathy: The Search for a Unifying Hypothesis Circ. Res., March 17, 2006; 98(5): 596 - 605. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Bertoni, D. C. Goff Jr, R. B. D'Agostino Jr, K. Liu, W. G. Hundley, J. A. Lima, J. F. Polak, M. F. Saad, M. Szklo, R. P. Tracy, et al. Diabetic Cardiomyopathy and Subclinical Cardiovascular Disease: The Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes Care, March 1, 2006; 29(3): 588 - 594. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Carbonara, R. Torella, and F. C. Sasso Impaired left ventricular function in obesity?: reply Eur. Heart J., December 2, 2005; 26(24): 2742 - 2743. [Full Text] [PDF] |
||||
![]() |
H. Wiggers, H. Norrelund, S. S. Nielsen, N. H. Andersen, J. E. Nielsen-Kudsk, J. S. Christiansen, T. T. Nielsen, N. Moller, and H. E. Botker Influence of insulin and free fatty acids on contractile function in patients with chronically stunned and hibernating myocardium Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H938 - H946. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. C. Sasso, O. Carbonara, R. Nasti, R. Marfella, K. Esposito, P. Rambaldi, L. Mansi, T. Salvatore, R. Torella, and D. Cozzolino Effects of insulin on left ventricular function during dynamic exercise in overweight and obese subjects Eur. Heart J., June 2, 2005; 26(12): 1205 - 1212. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. von Lewinski, S. Bruns, S. Walther, H. Kogler, and B. Pieske Insulin Causes [Ca2+]i-Dependent and [Ca2+]i-Independent Positive Inotropic Effects in Failing Human Myocardium Circulation, May 24, 2005; 111(20): 2588 - 2595. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. C. C. van der Horst, F. Zijlstra, A. W. J. van't Hof, C. J. M. Doggen, M.-J. de Boer, H. Suryapranata, J. C. A. Hoorntje, J.-H. E. Dambrink, R. O. B. Gans, H. J. G. Bilo, et al. Glucose-insulin-potassium infusion inpatients treated with primary angioplasty for acute myocardial infarction: The glucose-insulin-potassium study: a randomized trial J. Am. Coll. Cardiol., September 3, 2003; 42(5): 784 - 791. [Abstract] [Full Text] [PDF] |
||||
![]() |
V K Khoury, B Haluska, J Prins, and T H Marwick Effects of glucose-insulin-potassium infusion on chronic ischaemic left ventricular dysfunction Heart, January 1, 2003; 89(1): 61 - 65. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ramanathan, K. Shirota, S. Morita, T. Nishimura, Y. Huang, and S. N. Hunyor Glucose-insulin-potassium solution improves left ventricular mechanics in diabetes Ann. Thorac. Surg., February 1, 2002; 73(2): 582 - 587. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D Timmis Diabetes: Relationship to ischaemic heart disease Br. Med. Bull., October 1, 2001; 59(1): 159 - 172. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |